Michelle Mulherin (Mayo, Fine Gael)

Question 609: To ask the Minister for Health following the decision by the National Council for Pharma Economics on 22 September 2011 to approve the drug Fingolimod, Gilenya as a cost-effective therapy for the treatment of relapsing-remitting multiple sclerosis patients in the Irish healthcare setting, when this drug will be made available to all patients who need it; and if he will make a statement on the matter. [29211/12]

See this speech in context